Q2 2020 Neogenomics Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to your NeoGenomics' Second Quarter 2020 Earnings Call. (Operator Instructions)
At this time, it is my pleasure to turn the floor over to your host, Doug VanOort. Sir, the floor is yours.
Thank you, Karen, and good morning, everyone. I'd like to welcome everyone to NeoGenomics' Second Quarter 2020 Conference Call. Joining me from our Fort Myers headquarters, with social distancing precautions in place, are Kathryn McKenzie, our Chief Financial Officer; Rob Shovlin, President of our Clinical Division; and Bill Bonello, President of our Informatics Division and Director of Investor Relations. Joining the call via phone from locations across the country are George Cardoza, President of our Pharma Services Division; Dr. Larry Weiss, our Chief Medical Officer; and Doug Brown, our Chief Strategy and Corporate Development Officer.
Before we begin our prepared remarks, Bill Bonello will read the standard language about forward-looking statements.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |